// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Validity of ROX Index for Nasal High Flow Therapy in Critical Care

Raquel Mehmel D´Espiney Madeira Barbara - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Roxithromycin

Diagnostic yield of bronchioalveolar lavage in adult Intensive Care patients, and influence on management

Claire Pickering - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Altered iron metabolism and elevated cellular senescence in COPD small airway epithelial cells

Jonathan R. Baker - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Deferoxamine

Air liquid interface (ALI-grown immortalized human cell lines: a promising tractable model for human airway

Zeyad Alharbi - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Uteroglobin

Use of biomaterials to tissue engineer 3D models with lung organoids for in-vitro disease modelling

Isabel Uwagboe - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

HIF pathway activation is a core regulator of collagen structure-function in lung fibrosis

Christopher J Brereton - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Protease activated receptor 2 (PAR2 antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells

Mariarca Bailo - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Multiplex immunohistochemistry to investigate inflammatory cell spatial organisation and interactions in severe asthma

Latifa Chachi - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Alveolar presence of red blood cells correlates with alveolar macrophage iron levels in COPD

James Baker - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

3D imaging of London roadside particulate matter

Lisa Miyashita - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Monit

Exposure to textile microplastic fibers impairs epithelial growth

Fransien van Dijk - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Calcium-sensing receptor antagonists, calcilytics, prevent activation of human dendritic and epithelial cells by urban particulate matter

Bethan Mansfield - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Murine airway bronchodilation via Proteinase Activated Receptor 2

Kimberly Black - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Trypsin

PIERCEing ciliogenesis: defining a role for PIERCE1 and its’ paralog C15ORF65 in multiciliogenesis

Md. Miraj Kobad Chowdhury - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

COPD bronchial brush microbiome association with lung function and bronchial gene expression

Mohammadali Yavari Ramsheh - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Analysis of defective phagocytosis in COPD using super-resolution microscopy and automated bacterial quantification

Riccardo Wysoczanski - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Using mouse tracheal epithelial cells (mTECs to uncover an antiviral role for BPIFB1

Abdulaziz Alkhoshaiban - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Influenza

N/A

Human rhinovirus 16 infection of human macrophages disrupts Arpin expression impairing macrophage internalization: a potential link to exacerbation in chronic obstructive pulmonary disease?

Jamil Jubrail - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Airway hyperresponsiveness in offspring from mothers with allergic airway inflammation during pregnancy is muscarinic receptor and ADAM33 dependent

Marieke Wandel - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Circadian rhythmicity of sphingolipids in allergic asthma

Ran Wang - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Copyright © 2026. QuantiNova All rights reserved